APA (7th ed.) Citation

Monreal, E., Fernández-Velasco, J. I., García-Sánchez, M. I., Sainz de la Maza, S., Llufriu, S., Álvarez-Lafuente, R., . . . Villar, L. M. (2023). Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs. Archives of neurology (Chicago), 80(4), 397. https://doi.org/10.1001/jamaneurol.2023.0010

Chicago Style (17th ed.) Citation

Monreal, Enric, et al. "Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs." Archives of Neurology (Chicago) 80, no. 4 (2023): 397. https://doi.org/10.1001/jamaneurol.2023.0010.

MLA (9th ed.) Citation

Monreal, Enric, et al. "Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs." Archives of Neurology (Chicago), vol. 80, no. 4, 2023, p. 397, https://doi.org/10.1001/jamaneurol.2023.0010.